Neph3 Marker for Pancreatic Progenitor Cell Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods cannot effectively distinguish, detect, identify, and isolate pancreatic progenitor cells in a viable state without foreign genes or proteins, which is crucial for therapeutic applications and drug discovery, especially due to the scarcity of donors for cell transplantation therapy.
Innovation Solution
The use of the Nephrin-like 3 (Neph3) gene as a marker to selectively identify and isolate pancreatic progenitor cells by analyzing its expression pattern, which is similar to that of known indicators like Pdx-1 and Ptf1a, allowing for the development of methods to distinguish, detect, and isolate these cells using immunochemical techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to differentiate pancreatic multipotent progenitor cells from ES cells, then cell differentiation occurs, but the ability to specifically distinguish and isolate pancreatic progenitor cells is insufficient
Solution Approach 1:
The patent introduces Neph3 as an intermediary marker that specifically binds to pancreatic progenitor cells. This marker serves as a mediator between the complex ES cell population and the isolation process, enabling specific identification and separation of pancreatic progenitor cells without requiring complex multi-step differentiation protocols
Solution Approach 2:
The patent utilizes immunostaining with Neph3-specific antibodies to visually distinguish pancreatic progenitor cells from other cell types. The staining process creates detectable signal changes that allow precise identification and sorting of the target cell population based on Neph3 expression patterns
2Manufacturing precision
If sorting using specific antibodies is performed to enrich pancreatic multipotent progenitor cells, then cell purity increases, but the requirement for foreign genes and proteins is introduced
Solution Approach 1:
The patent exploits the endogenous Neph3 protein that is naturally expressed on pancreatic progenitor cells. Instead of introducing foreign markers, the method uses the cell's own Neph3 expression pattern for identification and isolation, thereby achieving high purity without incorporating foreign genetic material or exogenous proteins
Solution Approach 2:
The patent extracts and utilizes the specific Neph3 expression signature that is naturally present on pancreatic progenitor cells. By focusing on this endogenous marker, the method isolates the desired cell population based on their intrinsic molecular characteristics rather than foreign tags
3Productivity
If transplantation therapy is performed with scarce donors, then treatment is provided, but the availability of sufficient cell sources is limited
Solution Approach 1:
The patent enables preliminary identification and isolation of genuine pancreatic progenitor cells using Neph3 as a marker before transplantation. This preliminary sorting ensures that only cells with the correct lineage specification and differentiation potential are selected, improving both the availability of suitable cell sources and the reliability of transplantation outcomes
Solution Approach 2:
The patent employs Neph3 expression as a feedback marker to monitor and verify the identity of isolated cells. By using Neph3 staining and detection to confirm pancreatic progenitor cell identity before transplantation, the method provides quality control feedback that ensures safety and efficacy while maximizing the utility of available cell sources
Data Source
AI summary
The present invention provides markers that can selectively distinguish pancreatic progenitor cells. The present invention also provides methods for distinguishing pancreatic progenitor cells by using the markers as an indicator, and reagents to be used in the methods.The present inventors successfully identified the surface marker Nephrin-like 3 (Neph3) which is specifically expressed in pancreatic progenitor cells, and isolated pancreatic progenitor cells using the marker as an indicator or such. Viable pancreatic progenitor cells can be selected by using Neph3 as an indicator without using translated products and transcripts of any foreign genes. The marker is useful in preparing and identifying pancreatic progenitor cells which are applied to regenerative medicine or such for treatment of pancreatic diseases.